{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:24:14Z","timestamp":1772119454387,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00520-021-06738-0","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T19:03:16Z","timestamp":1641754996000},"page":"3463-3471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial"],"prefix":"10.1007","volume":"30","author":[{"given":"Katherine B.","family":"Peters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary L.","family":"Affronti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Woodring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Lipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Healy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"James E.","family":"Herndon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria W.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina M.","family":"Randazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Desjardins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry S.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"6738_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-1-60327-492-0_14","volume":"472","author":"H Ohgaki","year":"2009","unstructured":"Ohgaki H (2009) Epidemiology of brain tumors. Methods Mol Biol 472:323\u2013342. https:\/\/doi.org\/10.1007\/978-1-60327-492-0_14","journal-title":"Methods Mol Biol"},{"issue":"3 Suppl 6","key":"6738_CR2","first-page":"20","volume":"27","author":"M Gilbert","year":"2000","unstructured":"Gilbert M, Armstrong T, Meyers C (2000) Issues in assessing and interpreting quality of life in patients with malignant glioma. Semin Oncol 27(3 Suppl 6):20\u201326","journal-title":"Semin Oncol"},{"issue":"3","key":"6738_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1215\/15228517-2008-093","volume":"11","author":"R Liu","year":"2009","unstructured":"Liu R, Page M, Solheim K, Fox S, Chang SM (2009) Quality of life in adults with brain tumors: current knowledge and future directions. Neuro Oncol 11(3):330\u2013339. https:\/\/doi.org\/10.1215\/15228517-2008-093","journal-title":"Neuro Oncol"},{"issue":"20","key":"6738_CR4","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1200\/JCO.2001.19.20.4037","volume":"19","author":"M Klein","year":"2001","unstructured":"Klein M, Taphoorn MJ, Heimans JJ, van der Ploeg HM, Vandertop WP, Smit EF, Leenstra S, Tulleken CA, Boogerd W, Belderbos JS, Cleijne W, Aaronson NK (2001) Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. Journal of clinical oncology\u202f: official journal of the American Society of Clinical Oncology 19(20):4037\u20134047","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"3","key":"6738_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1200\/JCO.1994.12.3.627","volume":"12","author":"JR Crossen","year":"1994","unstructured":"Crossen JR, Garwood D, Glatstein E, Neuwelt EA (1994) Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. Journal of clinical oncology\u202f: official journal of the American Society of Clinical Oncology 12(3):627\u2013642","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"6738_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0167-8140(96)91782-X","volume":"41","author":"A Gregor","year":"1996","unstructured":"Gregor A, Cull A, Traynor E, Stewart M, Lander F, Love S (1996) Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiotherapy and oncology\u202f: journal of the European Society for Therapeutic Radiology and Oncology 41(1):55\u201359 (S0167-8140(96)91782-X[pii])","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"3","key":"6738_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11060-014-1574-3","volume":"120","author":"KB Peters","year":"2014","unstructured":"Peters KB, West MJ, Hornsby WE, Waner E, Coan AD, McSherry F, Herndon JE 2nd, Friedman HS, Desjardins A, Jones LW (2014) Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients. J Neurooncol 120(3):499\u2013506. https:\/\/doi.org\/10.1007\/s11060-014-1574-3","journal-title":"J Neurooncol"},{"issue":"10","key":"6738_CR8","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/neuonc\/nov084","volume":"17","author":"BR Page","year":"2015","unstructured":"Page BR, Shaw EG, Lu L, Bryant D, Grisell D, Lesser GJ, Monitto DC, Naughton MJ, Rapp SR, Savona SR, Shah S, Case D, Chan MD (2015) Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro Oncol 17(10):1393\u20131401. https:\/\/doi.org\/10.1093\/neuonc\/nov084","journal-title":"Neuro Oncol"},{"issue":"4","key":"6738_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/10790268.2016.1168587","volume":"39","author":"P Newland","year":"2016","unstructured":"Newland P, Starkweather A, Sorenson M (2016) Central fatigue in multiple sclerosis: a review of the literature. J Spinal Cord Med 39(4):386\u2013399. https:\/\/doi.org\/10.1080\/10790268.2016.1168587","journal-title":"J Spinal Cord Med"},{"issue":"5","key":"6738_CR10","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.ijrobp.2007.05.076","volume":"69","author":"JM Butler Jr","year":"2007","unstructured":"Butler JM Jr, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG (2007) A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys 69(5):1496\u20131501. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.05.076","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"6738_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/neuonc\/now007","volume":"18","author":"EQ Lee","year":"2016","unstructured":"Lee EQ, Muzikansky A, Drappatz J, Kesari S, Wong ET, Fadul CE, Reardon DA, Norden AD, Nayak L, Rinne ML, Alexander BM, Arvold ND, Doherty L, Stefanik J, LaFrankie D, Ruland SF, Pulverenti J, Smith KH, Gaffey SC, Hammond S, Wen PY (2016) A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy. Neuro Oncol 18(6):849\u2013854. https:\/\/doi.org\/10.1093\/neuonc\/now007","journal-title":"Neuro Oncol"},{"issue":"3","key":"6738_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/sj.npp.1301440","volume":"33","author":"EM Weerts","year":"2008","unstructured":"Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS, Frost JJ, McCaul ME (2008) Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects. Neuropsychopharmacology\u202f: official publication of the American College of Neuropsychopharmacology 33(3):653\u2013665. https:\/\/doi.org\/10.1038\/sj.npp.1301440","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"issue":"3","key":"6738_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.mehy.2008.06.048","volume":"72","author":"N Brown","year":"2009","unstructured":"Brown N, Panksepp J (2009) Low-dose naltrexone for disease prevention and quality of life. Med Hypotheses 72(3):333\u2013337. https:\/\/doi.org\/10.1016\/j.mehy.2008.06.048","journal-title":"Med Hypotheses"},{"issue":"4","key":"6738_CR14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0091-3057(03)00166-7","volume":"75","author":"V Rajashekara","year":"2003","unstructured":"Rajashekara V, Patel CN, Patel K, Purohit V, Yoburn BC (2003) Chronic opioid antagonist treatment dose-dependently regulates mu-opioid receptors and trafficking proteins in vivo. Pharmacol Biochem Behav 75(4):909\u2013913 (S0091305703001667)","journal-title":"Pharmacol Biochem Behav"},{"issue":"11","key":"6738_CR15","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3181\/0906-RM-189","volume":"234","author":"IS Zagon","year":"2009","unstructured":"Zagon IS, Rahn KA, Turel AP, McLaughlin PJ (2009) Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis. Exp Biol Med 234(11):1383\u20131392. https:\/\/doi.org\/10.3181\/0906-RM-189","journal-title":"Exp Biol Med"},{"issue":"4","key":"6738_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1526-4637.2009.00613.x","volume":"10","author":"J Younger","year":"2009","unstructured":"Younger J, Mackey S (2009) Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med 10(4):663\u2013672. https:\/\/doi.org\/10.1111\/j.1526-4637.2009.00613.x","journal-title":"Pain Med"},{"issue":"4","key":"6738_CR17","doi-asserted-by":"publisher","first-page":"e5180","DOI":"10.1371\/journal.pone.0005180","volume":"4","author":"JW Younger","year":"2009","unstructured":"Younger JW, Zautra AJ, Cummins ET (2009) Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology. PLoS ONE 4(4):e5180. https:\/\/doi.org\/10.1371\/journal.pone.0005180","journal-title":"PLoS ONE"},{"issue":"2","key":"6738_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ana.22006","volume":"68","author":"BA Cree","year":"2010","unstructured":"Cree BA, Kornyeyeva E, Goodin DS (2010) Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis. Ann Neurol 68(2):145\u2013150. https:\/\/doi.org\/10.1002\/ana.22006","journal-title":"Ann Neurol"},{"issue":"8","key":"6738_CR19","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1177\/1352458508095828","volume":"14","author":"M Gironi","year":"2008","unstructured":"Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G (2008) A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Mult Scler 14(8):1076\u20131083. https:\/\/doi.org\/10.1177\/1352458508095828","journal-title":"Mult Scler"},{"issue":"8","key":"6738_CR20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1177\/1352458510366857","volume":"16","author":"N Sharafaddinzadeh","year":"2010","unstructured":"Sharafaddinzadeh N, Moghtaderi A, Kashipazha D, Majdinasab N, Shalbafan B (2010) The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial. Mult Scler 16(8):964\u2013969. https:\/\/doi.org\/10.1177\/1352458510366857","journal-title":"Mult Scler"},{"issue":"15","key":"6738_CR21","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1177\/1535370217724791","volume":"242","author":"MD Ludwig","year":"2017","unstructured":"Ludwig MD, Zagon IS, McLaughlin PJ (2017) Featured Article: Serum [Met(5)]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone. Exp Biol Med (Maywood) 242(15):1524\u20131533. https:\/\/doi.org\/10.1177\/1535370217724791","journal-title":"Exp Biol Med (Maywood)"},{"issue":"8","key":"6738_CR22","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1177\/1352458508095828","volume":"14","author":"M Gironi","year":"2008","unstructured":"Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G (2008) A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 14(8):1076\u20131083. https:\/\/doi.org\/10.1177\/1352458508095828","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"4","key":"6738_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00520-004-0734-y","volume":"13","author":"S Van Belle","year":"2005","unstructured":"Van Belle S, Paridaens R, Evers G, Kerger J, Bron D, Foubert J, Ponnet G, Vander Steichel D, Heremans C, Rosillon D (2005) Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Supportive care in cancer\u202f: official journal of the Multinational Association of Supportive Care in Cancer 13(4):246\u2013254. https:\/\/doi.org\/10.1007\/s00520-004-0734-y","journal-title":"Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"2","key":"6738_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cncr.10245","volume":"94","author":"D Cella","year":"2002","unstructured":"Cella D, Lai JS, Chang CH, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94(2):528\u2013538. https:\/\/doi.org\/10.1002\/cncr.10245","journal-title":"Cancer"},{"issue":"5","key":"6738_CR25","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","volume":"41","author":"GR Norman","year":"2003","unstructured":"Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41(5):582\u2013592. https:\/\/doi.org\/10.1097\/01.MLR.0000062554.74615.4C","journal-title":"Med Care"},{"issue":"2","key":"6738_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejca.2008.10.029","volume":"45","author":"MJ Ratain","year":"2009","unstructured":"Ratain MJ, Sargent DJ (2009) Optimising the design of phase II oncology trials: the importance of randomisation. Eur J Cancer 45(2):275\u2013280. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.029","journal-title":"Eur J Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06738-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06738-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06738-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T16:08:13Z","timestamp":1645200493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06738-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["6738"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06738-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-172964\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Duke University Institutional Review Board and assigned number was Pro00027661 after receiving ethical approval from this designee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patients were presented with the study and were provided with written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}